Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 48.55%
March 31, 2026 35.16%
December 31, 2025 50.45%
September 30, 2025 51.20%
June 30, 2025 52.11%
March 31, 2025 49.01%
December 31, 2024 9.27%
September 30, 2024 48.07%
June 30, 2024 7.45%
March 31, 2024 -4.34%
December 31, 2023 3.90%
September 30, 2023 15.81%
June 30, 2023 23.03%
March 31, 2023 18.80%
Date Value
December 31, 2022 -0.44%
September 30, 2022 22.30%
June 30, 2022 19.55%
March 31, 2022 11.14%
December 31, 2021 -14.58%
September 30, 2021 22.33%
June 30, 2021 14.09%
March 31, 2021 -677.4%
December 31, 2020 -41.07%
September 30, 2020 0.00%
June 30, 2020 0.00%
March 31, 2020 -56.50%
December 31, 2019 -258.6%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Champions Oncology, Inc. 48.48%
Medpace Holdings, Inc. 27.56%
Avantor, Inc. 31.73%
Personalis, Inc. 21.21%
Adaptive Biotechnologies Corp. 70.15%

Gross Profit Margin (Quarterly) Related Metrics